Skip to content

A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre-hospital setting

A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre-hospital setting

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000410257
Enrollment
50
Registered
2009-06-03
Start date
2009-07-04
Completion date
2010-06-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Purpose of trial is to compare Continuous positive airway pressure (CPAP) versus conventional therapy of inspired postive pressure ventilation with bag valve mask.

Interventions

Continuous postive airway pressure (CPAP) at 10 cm H20 with face mask will be used for patients in acute respiratory distress with clnical diagnosis of acute cardiogenic pulmonary oedema) ACPO. The duration of the treatment will be time transported and treated by paramedics. All other treatments will be cosistant between groups (Glycerine trinitrate (GTN) spray incremental doses every 5 min of 400 mcg up to 1600 mcg sublingual with repreated 1600 mcg every 5 min as long as BP >100 systolic, Frus

Continuous postive airway pressure (CPAP) at 10 cm H20 with face mask will be used for patients in acute respiratory distress with clnical diagnosis of acute cardiogenic pulmonary oedema) ACPO. The duration of the treatment will be time transported and treated by paramedics. All other treatments will be cosistant between groups (Glycerine trinitrate (GTN) spray incremental doses every 5 min of 400 mcg up to 1600 mcg sublingual with repreated 1600 mcg every 5 min as long as BP >100 systolic, Frusemide dose 40 mg increments every 20 min to max 80 mg intravenous)

Sponsors

Tasmanian Ambulance Service department of health and human services
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Age over 18 years Crackles on auscultation of the lungs Breathlessness and increased work of breathing History of ischemic heart disease (IHD) or risk factor contributing to IHD

Exclusion criteria

Other respiratory conditions (particularly asthma and Chronic obstructive pulmonary disease (COPD)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026